Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume 25, Issue 6, Pages 1160-1173
Publisher
Springer Nature
Online
2018-01-23
DOI
10.1038/s41418-017-0034-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer
- (2016) X.C. Peng et al. Journal of Proteomics
- mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle
- (2016) I. Ben-Sahra et al. SCIENCE
- NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth
- (2015) Xiaojun Zha et al. CANCER LETTERS
- Pyruvate kinase M2 and cancer: an updated assessment
- (2014) Mohd Askandar Iqbal et al. FEBS LETTERS
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/ AKT/mTOR Pathway in Cancer
- (2013) Faton Agani et al. CURRENT CANCER DRUG TARGETS
- The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications
- (2013) Xiangli Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- PGAMgnam Style: A Glycolytic Switch Controls Biosynthesis
- (2012) Barbara Chaneton et al. CANCER CELL
- Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth
- (2012) Taro Hitosugi et al. CANCER CELL
- CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth
- (2012) Claudia Capparelli et al. CELL CYCLE
- Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway
- (2012) Naifa L. Busaidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Lactate Dehydrogenase B Is Critical for Hyperactive mTOR-Mediated Tumorigenesis
- (2011) X. Zha et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Regulation of Glycolytic Enzyme Phosphoglycerate Mutase-1 by Sirt1 Protein-mediated Deacetylation
- (2011) William C. Hallows et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
- (2011) Q. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
- (2010) Sybille Mazurek INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade
- (2010) Jianhui Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells
- (2010) M. G. Vander Heiden et al. SCIENCE
- A hypomorphic allele of Tsc2 highlights the role of TSC1/TSC2 in signaling to AKT and models mild human TSC2 alleles
- (2009) Kristen Pollizzi et al. HUMAN MOLECULAR GENETICS
- Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma
- (2008) Ai-Wu Ke et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search